Observational studyCancer immunology, immunotherapy : CII2024

Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations.

Lorena Incorvaia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.